Table 1.
Inhibitors | Concentration (μm) | % Inhibition (head ganglia membranes) | % Inhibition (kidney membranes)1-a |
---|---|---|---|
RB104 | 1 | 87 | 91 |
HACBO-Gly | 10 | 91 | 74 |
Thiorphan | 10 | 41 | 33 |
Phosphoramidon | 10 | 41 | 45 |
1-10 Phenantroline | 5 | 100 | 100 |
Captopril | 10 | 11 | 0 |
PMSF | 100 | 0 | 0 |
Plasma membranes from head ganglia or kidney [results from Bawab et al. (1993)] were incubated, before the addition of the [3H]Leu-enkephalin, in the absence or presence of various peptidase inhibitors. The enzymatic assays were performed as indicated in Materials and Methods. Results are expressed as a percentage of inhibition of substrate degradation. The percentage inhibition was calculated by comparing the radioactivity under the Tyr-Gly-Gly peak in the presence and absence of inhibitors.